CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		10 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2018	Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ 406,558	$ (719,840)	$ (1,171,723)	$ (124,907)	$ (313,282)	$ (1,296,630)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization					97,065	223,783
Amortization of debt discount on notes payable					317,843	110,913
Amortization of right of use assets					687,226	437,384
Share-based payment compensation					7,570	25,482
Provision for (recovery of) returns and doubtful accounts					(81,244)	29,346
Deferred income taxes (benefit)					0	0
Changes in operating assets and liabilities:
Accounts receivable					1,628,983	1,915,823
Prepaid expenses and other current assets					277,525	181,764
Contract assets					399,320	92,724
Inventory					14,571	(90,045)
Other assets					(7,160)	(551,582)
Accounts payable					(605,831)	527,623
Accrued expenses and other long-term liabilities					(298,558)	(262,193)
Operating lease liabilities					(810,426)	(568,539)
Deferred revenue					(1,988,705)	(699,893)
Net cash provided by (used in) operating activities					(675,103)	75,960
Cash flows from investing activities:
Purchases of property and equipment					0	(179,048)
Security deposits					0	(6,398)
Purchase of intangible assets					(35,655)	(41,736)
Net cash provided by (used in) investing activities					(35,655)	(227,182)
Cash flows from financing activities:
Proceeds from issuance of PPP loan					754,000	0	$ 1,000,000	$ 1,000,000
Payments of long term-debt					0	(489,321)		(489,321)
Net cash provided by (used in) financing activities					754,000	(489,321)
Effect of exchange rate changes on cash and cash equivalents					(4,057)	(18,181)
Net increase (decrease) in cash and cash equivalents					39,185	(658,724)
Cash and cash equivalents, beginning of period		1,475,166		3,059,677	1,475,166	3,059,677		3,059,677
Cash and cash equivalents, end of period	1,514,351		2,400,953		1,514,351	2,400,953	$ 3,059,677	$ 1,475,166
Supplemental disclosures:
Cash paid for interest					110,708	119,040
Non-cash investing and financing activities:
Undistributed Series A redeemable convertible preferred stock dividends					546,355	503,580
Accretion of Series A redeemable convertible preferred stock	$ 165,141	$ 26,090	$ 134,223	$ 129,239	$ 191,231	$ 263,462